Becker's Hospital Review

UPMC pharmacy leader: ‘Cost Plus’ models threaten PBMs

The rise of more transparent, “Cost Plus” pharmacy models is stirring debate within the pharmaceutical space as smaller players put pressure on the large PBMs. In January 2022, entrepreneur Mark Cuban ...
Morningstar

Mark Cuban Cost Plus Drug Company Expands Access with Addition of Starjemza® (ustekinumab-hmny) to Give Patients More Power Over Prescription Costs

DALLAS, Nov. 6, 2025 /PRNewswire/ -- Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) today announced the addition of Starjemza®, a new biosimilar medication, to its growing portfolio of affordable ...
Drug Store News

Lumicera partners with Costco Pharmacy to deliver cost-plus specialty pharmacy

Lumicera Health Services, a specialty pharmacy solutions company, announced a partnership with Costco Wholesale Corporation to expand cost-plus specialty pharmacy in the marketplace and offer a broad ...
Fierce Healthcare

Mark Cuban's Cost Plus Drugs, Humana exploring partnership to tackle employer drug costs

Mark Cuban's Cost Plus Drugs and Humana are exploring a potential partnership to help lower the cost of prescription drugs for employers. Cuban, an entrepreneur, businessman and TV personality who ...
Becker's Hospital Review

Cost Plus platform adds tools to cut drug costs

Mark Cuban Cost Plus Drugs has expanded its partnership with GraphiteRx to support the Cost Plus Marketplace for Businesses. The platform combines Cost Plus Drugs’ pricing model with GraphiteRx’s ...